Evaluating TIMP-2 and IGFBP-7 as a predictive tool for kidney injury in ureteropelvic junction obstruction

Carregando...
Imagem de Miniatura
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2022
Título da Revista
ISSN da Revista
Título do Volume
Editora
BRAZILIAN SOC UROL
Citação
INTERNATIONAL BRAZ J UROL, v.48, n.2, p.284-293, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
A major challenge in the management of ureteropelvic junction obstruction (UPJO) is the selection of patients who would benefit from surgical treatment. Tissue inhibitor metalloproteinase-2 (TIMP-2) and insulin-like growth factor-binding protein 7 (IGFBP7) indicate renal cell stress and are associated with cell cycle arrest. The [TIMP-2] [IGFBP7] ratio (Nephrocheck (R)) has been recently applied in patients in intensive care units patients to predict the development of acute kidney injury. In this study, we evaluated the performance of these biomarkers performance to distinguishing obstructive hydronephrosis (HN) from non-obstructive HN. Materials and Methods: Consecutive patients with UPJO were enrolled in this study. Urinary [TIMP-2] [IGFBP7] and clinical characteristics (hydronephrosis grade, differential renal function, and drainage half-time) were measured in the following groups: 26 children with obstructive HN at initial diagnosis (group IA) and after six months of dismembered pyeloplasty (group 1B); 22 children with non-obstructive HN (group 2), and 26 children without any urinary tract condition, as the control group (group 3). Results: Comparing the initial samples, [TIMP-2] [IGFBP7] had higher levels in the HN groups and lower levels in the control group; however, no difference was observed between the HN groups (obstructive vs. non-obstructive). After six months of followup, patients who underwent dismembered pyeloplasty showed stability in the urinary concentration of [TIMP-2] [IGFBP7]. All patients with [TIMP-2] [IGFBP7] higher than 1.0 (ng/mL)(2)/1000 had diffuse cortical atrophy on ultrasonography. Conclusions: We showed that urinary levels of urinary [TIMP-2] [IGFBP7] are higher in children with HN than controls. Nephrocheck (R) is not reliable in predicting the need for surgical intervention for pediatric patients with UPJO.
Palavras-chave
Cakut [Supplementary Concept], Urinary Tract, Child, Biomarkers
Referências
  1. Alge JL, 2015, CLIN J AM SOC NEPHRO, V10, P147, DOI 10.2215/CJN.12191213
  2. Arora S, 2015, J PEDIATR UROL, V11, DOI 10.1016/j.jpurol.2015.02.008
  3. BLYTH B, 1993, J UROLOGY, V149, P693, DOI 10.1016/S0022-5347(17)36185-2
  4. Chevalier RL, 2010, PEDIATR NEPHROL, V25, P687, DOI 10.1007/s00467-009-1316-5
  5. Emlet DR, 2017, AM J PHYSIOL-RENAL, V312, pF284, DOI 10.1152/ajprenal.00271.2016
  6. Eskild-Jensen A, 2005, J UROLOGY, V173, P1471, DOI 10.1097/01.ju.0000157384.32215.fe
  7. Kashani K, 2013, CRIT CARE, V17, DOI 10.1186/cc12503
  8. Koff SA, 2000, UROLOGY, V55, P609, DOI 10.1016/S0090-4295(00)00459-3
  9. Lee Hae-Jeong, 2005, RSNA, P275
  10. Meersch M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110865
  11. Nalesso F, 2020, INT J NEPHROL RENOV, V13, P85, DOI 10.2147/IJNRD.S198222
  12. Olsen LH RY, 2016, CAMPELL WALSH UROLOG, V11th
  13. Onen Abdurrahman, 2007, J Pediatr Urol, V3, P200, DOI 10.1016/j.jpurol.2006.08.002
  14. Ortega LM, 2018, NEFROLOGIA, V38, P361, DOI 10.1016/j.nefro.2017.11.013
  15. Radmayr C., 2018, EAU GUIDELINES
  16. Ronco C, 2019, LANCET, V394, P1949, DOI 10.1016/S0140-6736(19)32563-2
  17. Schwartz GJ, 2009, CLIN J AM SOC NEPHRO, V4, P1832, DOI 10.2215/CJN.01640309
  18. Ulman I, 2000, J UROLOGY, V164, P1101, DOI 10.1016/S0022-5347(05)67262-X
  19. Wang W, 2016, NEPHROL DIAL TRANSPL, V31, P1437, DOI 10.1093/ndt/gfv448
  20. Westhoff JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143628
  21. Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144